This Medical Life

Episode 84: Prostate Cancer | Donald Gleason’s Legacy

This Medical Life

Show Notes

In 1966, the Chief of Urology asked the Chief of Pathology at the Minneapolis VA Hospital to develop a system to communicate the results of prostate cancer to researchers. The Chief of Pathology was Donald Gleason and he developed a system that would revolutionise our understanding of prostate cancer. Today, every prostate cancer worldwide is classified using the Gleason score, named after Donald Gleason. Prostate cancer is one of the most common cancers worldwide and accounts for 15% of all male cancers. Its incidence of prostate cancer is estimated to double by 2040. This is the story of prostate cancer. Our special guests: Professor Fiona Maclean is a Clinical Professor, Anatomical Pathologist, author, past President of the Australasian Division of the International Academy of Pathology (IAP), and advisor in Pathology Artificial Intelligence. Dr Joanna Olphert is a urologist and robotic surgeon involved in genitourinary reconstructive surgery, robotic uro-oncology, and open complex peritoneal surgery. Dr Carole Harris is a medical oncologist, senior lecturer, and senior research fellow. See omnystudio.com/listener for privacy information.

More from This Medical Life

Oct 19, 2026

Pleomorphic adenoma is the most common parotid tumour. ENT surgeon Dr Rowan Valentine covers assessment, red flags and surgery in Episode 112.

Oct 5, 2026

Professor Ken Sikaris explains the 2026 Australian prostate cancer early detection guidelines: new PSA thresholds by age, MRI's role and why free PSA is gone.

Sep 21, 2026

A patient with 200 sleep attacks a day helped define narcolepsy in 1880. Di Spillaine and Professor Robert Adams on symptoms, diagnosis and treatment today.

Sep 14, 2026

Dr Louise Stone on a decade of research into sexual harassment in medicine, why it persists, and what actually helps a colleague or trainee.

Aug 31, 2026

A 1901 case first identified Alzheimer's disease. Dr Daniel Clarke and Dr Gemma Daley on today's presentation, workup and new blood biomarker tests.

See all episodes →